1. Imaging Biomarkers in Immunotherapy
   Rosalyn A. Juergens et al, 2016, Biomarkers in Cancer CrossRef
2. The Positron Emission Tomography Tracer 3’-Deoxy-3’-[18F]Fluorothymidine ([18F]FLT) Is Not Suitable to Detect Tissue Proliferation Induced by Systemic Yersinia enterocolitica Infection in Mice
   Stefan Wiehr et al, 2016, PLOS ONE CrossRef
3. Potential novel imaging targets of inflammation in cardiac sarcoidosis
   Jakob Park et al, 2022, Journal of Nuclear Cardiology CrossRef
4. False-Positive 18F-FDG and 18F-Fluorothymidine Uptake in a Patient With Round Atelectasis
   Takashi Norikane et al, 2020, Clinical Nuclear Medicine CrossRef
5. 18F-FDG and 18F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes
   Sampanna Jung Rayamajhi et al, 2016, Annals of Nuclear Medicine CrossRef
6. PET Radiopharmaceuticals for Specific Bacteria Imaging: A Systematic Review
   Sveva Auletta et al, 2019, Journal of Clinical Medicine CrossRef
7. Immuno-Oncology, Imaging Biomarkers and Response to Chemotherapy in Cancer Treatment
   Alireza Ziaei et al, 2020, Translational Studies on Inflammation CrossRef
8. PET Imaging of T Cells: Target Identification and Feasibility Assessment
   Yves P. Auberson et al, 2018, ChemMedChem CrossRef
9. 18F-FDG, as a single imaging agent in assessing cancer, shows the ongoing biological phenomena in many domains
   Thomas C. Kwee et al, 2016, Nuclear Medicine Communications CrossRef
10. Radiopharmaceuticals for PET Imaging of Infection
    Alfred O. Ankrah et al, 2020, Nuclear Medicine in Infectious Diseases CrossRef
11. Overview of Positron-Emission Tomography Tracers for Metabolic Imaging
    Ephraim Parent et al, 2018, Imaging and Metabolism CrossRef